As a first-time investor, it can be daunting trying to figure out where to put your money. But don’t worry, we’ve got you covered. Join us as we cover different types of investments!

What are the most popular types of investments? | Get Rich Slow Club

Whilst none of us are the next Warren Buffett, we have the ability to "own a piece of America", as he often suggests. For this reason, we're sharing the 10 most most popular US stocks on Pearler. 

Check out Pearler's most popular US stocks

Think of community data as a compass: you can choose any stock you want, but our community keeps pointing in the same general direction - simple, diversified, and cheap ETFs. Let's take a look at the 10 most popular ETFs on Pearler.

These are Pearler's most popular ETFs

CATALYST PHARMACEUTICALS INC (CPRX:US) Share Price | Pearler

IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

The iShares S&P 500 ETF seeks to track the investment results of an index composed of large-capitalisation U.S. equities.

iShares S&P 500 Etf

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

Vanguard Australian Shares Index ETF (ASX: VAS) seeks to track the performance of the ASX 300 index before account fees, expenses, and taxes. The index tracks the top 300 companies on the Australian Securities Exchange (ASX). These are mostly large and established Australian companies. It is a popular choice among passive individual investors who don't have the time or the expertise to actively invest in stocks.

Vanguard Australian Shares Index Etf

Cooper-Standard Holdings Inc. is a manufacturer of sealing, fuel and brake delivery and fluid transfer systems. It operates through four segments: North America, Europe, Asia Pacific and South America. Its organizational structure includes a global automotive business and Advanced Technology Group. Its products are used in passenger vehicles and light trucks that are manufactured by automotive original equipment manufacturers and replacement markets. The Company operates in 78 manufacturing locations and 54 design, engineering, administrative and logistics locations. Its automotive business is focused on the passenger car and light truck market, up to and including class three full-size, full-frame trucks. The Company supplies its products to original equipment manufacturers (OEMs). The Company’s other OEMs include Renault-Nissan, BMW, Toyota, Volvo, Jaguar/Land Rover, Honda and various other OEMs based in China.

Cooper-Standard Holdings Inc.

Copart, Inc. (Copart) is a provider of online auctions and vehicle remarketing services. The Company provides vehicle sellers with a full range of services to process and sell vehicles over the Internet through the Company’s Virtual Bidding Third Generation (VB3) Internet auction-style sales technology. The Company sells vehicles principally to licensed vehicle dismantlers, rebuilders, repair licensees, used vehicle dealers, exporters, and directly to the general public. The Company operates through two segments: United States and International. Its service offerings include Copart Access, Copart ProQuote, IntelliSeller and Estimating Services. Through Copart Access, it enables Internet-based service for vehicle sellers to assign vehicles for sale, check sales calendars, view vehicle images and history, Its vehicle sellers consist primarily of insurance companies, banks, finance companies, charities, fleet operators, dealers, vehicle rental companies, and individuals.

Copart, Inc.

Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases. With the patient focus, the Company is engaged in developing a robust pipeline of cutting-edge, medicines for rare diseases. The Company's New Drug Application for FIRDAPSE (amifampridine) tablets 10 milligrams (mg) for the treatment of adults with Lambert-Eaton myasthenic syndrome (LEMS). The Company's FIRDAPSE is commercially available in the United States as a treatment for adults with LEMS. The Company also has FYCOMPA (perampanel) CIII, a prescription medicine approved in people with epilepsy aged four and older alone or with other medicines to treat partial-onset seizures with or without secondarily generalized seizures and with other medicines to treat primary generalized tonic-clonic seizures for people with epilepsy aged 12 and older.

CATALYST PHARMACEUTICALS INC

Enphase Energy, Inc. is a global energy technology company. The Company designs, develops, manufactures and sells home energy solutions that manage energy generation, energy storage and control and communications on one platform. Its Enphase Energy System brings a high technology, networked approach to solar generation plus energy storage, by leveraging its design for power electronics, semiconductors and cloud-based software technologies. Its integrated approach to energy solutions increases a home energy potential while, providing advanced monitoring and remote maintenance capabilities. The Enphase Energy System uses a single technology platform for seamless management of the whole solution, enables rapid commissioning with the Enphase Installer Application, consumption monitoring with Enphase IQ Gateway with IQ Combiner+, Enphase Application, a cloud-based energy management platform and its IQ Battery. Its commercial systems have been deployed in approximately 145 countries.

Enphase Energy, Inc.

Exelixis, Inc. is an oncology company. The Company is engaged in developing medicines and combination regimens at the forefront of cancer care. It has four products, including its flagship molecule, cabozantinib, which is an inhibitor of multiple tyrosine kinases, including MET, AXL, VEGF receptors and RET. Cabozantinib is approved as CABOMETYX tablets used for advanced renal cell carcinoma (RCC), both alone and in combination with Bristol-Myers Squibb Company's (BMS) OPDIVO (nivolumab), for hepatocellular carcinoma (HCC) and for radioactive iodine (RAI)-refractory differentiated thyroid cancer (DTC). Cabozantinib is also approved as COMETRIQ capsules for metastatic medullary thyroid cancer (MTC). Its other two products are COTELLIC, an inhibitor of MEK approved as part of multiple combination regimens to treat specific forms of advanced melanoma and MINNEBRO an oral, non-steroidal, selective blocker of the mineralocorticoid receptor (MR) approved the treatment of hypertension.

Exelixis, Inc.

General Electric Company (GE) is a high-tech industrial company. The Company operates through three segments: Aerospace, Renewable Energy, and Power. Its Aerospace segment designs and produces commercial and military aircraft engines, integrated engine components, electric power, and mechanical aircraft systems. This segment also provides aftermarket services to support its products. Under Renewable Energy segment, its portfolio of business units includes onshore and offshore wind, blade manufacturing, grid solutions, hydro, storage, hybrid renewables and digital services offerings. Under Power segment its products and technologies harness resources, such as oil, gas, fossil, diesel and nuclear to produce electric power and include gas and steam turbines, full balance of plant, upgrade and service solutions, as well as data-leveraging software. Its Power segment is organized into gas power, steam power and power conversion, nuclear and other.

General Electric Company

Genmab A/S is a Denmark-based international biotechnology company. It specializes in the creation and development of antibody therapeutics for the treatment of cancer. The Company is the creator of the approved antibodies: DARZALEX (daratumumab) for the treatment of certain multiple myeloma indications, Kesimpta for the treatment of adults with relapsing forms of multiple sclerosis, TEPEZZA (teprotumumab) for the treatment of thyroid eye disease and FASPRO, for the treatment of adult patients with certain multiple myeloma indications. The first approved Genmab created therapy Arzerra, approved for the treatment of certain chronic lymphocytic leukemia indications, is available in Japan and is also available in other territories via compassionate use or oncology access programs. Genmab develops a broad clinical and pre-clinical product pipeline, and owns four antibody technologies, DuoBody bispecific platform, HexaBody platform, DuoHexaBody platform & HexElect platform.

Genmab A/S

Equinix, Inc. (Equinix) is a digital infrastructure company. The Company's platform Equinix, combines a global footprint of International Business Exchange (IBX) data centers in the Americas (AMER), Asia-Pacific (APAC), and Europe, the Middle East and Africa (EMEA) regions, interconnection solutions, edge services, business and digital ecosystems, and consulting and support. Equinix’s interconnected data centers around the world allows it customers to bring together and interconnect the infrastructure they need to track their digital advantage. Equinix interconnection offerings include Equinix Fabric provides secure, on-demand, software-defined interconnection. Equinix enables businesses to connect globally to their choice of thousands of networking, storage, compute, and application service providers in the industry’s infrastructure ecosystem. Its Cross Connects provide a point-to-point cable link between two Equinix customers in the same data center.

CPRX

Buy

👑 Overview

📈

N/A

Annual Growth

🌏

0

Pearlers Invested

Key information

🔎 Fund Overview

Price History*

Unsure how much or often to invest?

🗓️ Investing frequency calculator

💵 Investing amount calculator

⏱️ Investing duration calculator

💵

6.50 AUD*

Purchase Fee

💼

N/A

Management Fee

💸

Want to know the long term costs?

Calculate the historic long term costs to hold your investments

Technical Info

$11.50

How our community is investing

0

N/A

N/A

N/A

N/A

CPRX investor breakdown

💵 Income of investors

👶 Age of investors

🙋 Legal gender of investors

$165.20 USD

Find Out More

$19.13 USD

Find Out More

$102.74 USD

Find Out More

$40.62 USD

Find Out More

$729.15 USD

Find Out More

$11.61 USD

Find Out More

$87.88 USD

Find Out More

Buy